Evidence map›Paper›PMID 16199580›Full record

ArticleJournal of bacteriology2005

Rejection of impassable substrates by Yersinia type III secretion machines.

Joseph A Sorg, Nathan C Miller, Melanie M Marketon, Olaf Schneewind

Open access · greenAbstract read
In one paragraph

Article in Journal of bacteriology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 36 citations in OpenAlex.

  1. Evolution of N-terminal mechanical lability as a determinant for Type III secretion.Protein science : a publication of the Protein Society · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Identification of secreted bacterial proteins by noncanonical amino acid tagging.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The blueprint of the type-3 injectisome.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2012
    Review
  14. Article
  15. Article
  16. Article
  17. Remembering Malcolm J. Casadaban.Journal of bacteriology · 2010
    Article
  18. Article
  19. Elucidation of a pH-folding switch in the Pseudomonas syringae effector protein AvrPto.Proceedings of the National Academy of Sciences of the United States of America · 2009
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Joseph A SorgDepartment of Microbiology, University of Chicago, Illinois 60637, USA.
Nathan C Miller
Melanie M Marketon
Olaf Schneewind
University of Chicago · US

Funding

Vaccines and Therapies Against BotulismU54AI057153 · NIAID · UNIVERSITY OF CHICAGO · PI SHUMAN, HOWARD A · 2003 to 2013
$87.6M
Molecular And Cellular Biology Training ProgramT32GM007183 · NIGMS · UNIVERSITY OF CHICAGO · PI GLICK, BENJAMIN S, RICE, PHOEBE A · 1985 to 2021
$23.9M
Yersinia Type III Transport of Yop Proteins into Immune CellsR01AI042797 · NIAID · UNIVERSITY OF CHICAGO · PI SCHNEEWIND, OLAF · 1998 to 2013
$4.3M
NIAID NIH HHS 1-U54-AI-057153NIAID NIH HHS AI42797NIAID NIH HHS R01 AI042797NIAID NIH HHS U54 AI057153NIGMS NIH HHS T32 GM007183NIGMS NIH HHS T32GM007183
6 · The paper itself

Abstract

Type III machines of pathogenic Yersinia spp. transport Yop proteins across the bacterial envelope into host cells. Translational fusions of yopE to the dihydrofolate reductase gene (dhfr) or the beta-galactosidase gene (lacZ) generate hybrid proteins that block type III injection of Yop proteins into host cells, consistent with the canonical view that impassable DHFR and LacZ hybrids jam secretion machines. Mutations in repressors of posttranscriptional gene regulation, Yersinia enterocolitica yscM1 and yscM2 as well as Yersinia pestis lcrQ, relieve the YopE-DHFR-imposed blockade and restore type III injection into host cells. Genetic suppression of the type III blockade does not, however, promote YopE-DHFR secretion. A model is proposed whereby rejection of YopE-DHFR from the secretion pathway inhibits type III gene expression.

Indexed as

Bacterial Outer Membrane ProteinsBacterial Proteinsbeta-GalactosidaseBodily SecretionsGene Expression Regulation, BacterialHeLa CellsHumansLac OperonRecombinant Fusion ProteinsSubstrate SpecificityTetrahydrofolate DehydrogenaseTrans-ActivatorsVirulenceYersinia enterocoliticaYersinia InfectionsYersinia pestisBacterial Outer Membrane ProteinsBacterial Proteinsbeta-GalactosidaseRecombinant Fusion ProteinsSycE protein, YersiniaTetrahydrofolate DehydrogenaseTrans-ActivatorsyopE protein, Yersinia

Identifiers

PMID16199580
PMCPMC1251613
OpenAlexW2095952967

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.